We are live on ! Find out more
IPCI

Intellipharmaceuticals International Inc.
IPCI

Delisted

IPCI was delisted on the 20th of March, 2019.

Back to rankings

12 hedge funds and large institutions have $7.6M invested in Intellipharmaceuticals International Inc. in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

20% more funds holding

Funds holding: 10 → 12 (+2)

10% more capital invested

Capital invested by funds: $6.92M → $7.6M (+$675K)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$106K
2
AIG
American International Group
New York
+$7.86K
3
AllianceBernstein
AllianceBernstein
Tennessee
+$1.63K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$550

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$402K
2
FNYS
First New York Securities
New York
-$296K

IPCI Hedge Fund Activity: Q3 2013 in Review

12 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q3 2013, worth a combined $7.6M — up 9.7% from $6.92M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IPCI positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $106K. The largest seller was Broadfin Capital, cutting an estimated $402K.

  • 12 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q3 2013, up from 10 in Q2 2013.
  • Funds reported $7.6M of Intellipharmaceuticals International Inc. stock for Q3 2013, up 9.7% quarter-over-quarter.
  • 3 funds opened new Intellipharmaceuticals International Inc. positions in Q3 2013 and 1 closed out, a net change of +2 holders.
  • The largest Intellipharmaceuticals International Inc. buyer in Q3 2013 was Deutsche Bank, an estimated $106K added.
  • The largest Intellipharmaceuticals International Inc. seller in Q3 2013 was Broadfin Capital, an estimated $402K sold.

Based on aggregated 13F filings for Q3 2013.